| Literature DB >> 21169126 |
Laura Dioni1, Mirjam Hoxha, Francesco Nordio, Matteo Bonzini, Letizia Tarantini, Benedetta Albetti, Alice Savarese, Joel Schwartz, Pier Alberto Bertazzi, Pietro Apostoli, Lifang Hou, Andrea Baccarelli.
Abstract
BACKGROUND: Shortened leukocyte telomere length (LTL) is a marker of cardiovascular risk that has been recently associated with long-term exposure to ambient particulate matter (PM). However, LTL is increased during acute inflammation and allows for rapid proliferation of inflammatory cells. Whether short-term exposure to proinflammatory exposures such as PM increases LTL has never been evaluated.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21169126 PMCID: PMC3094411 DOI: 10.1289/ehp.1002486
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Blood leukocytes counts, LTL, hTERT mRNA expression, and hTERT promoter methylation measured in 63 foundry workers at baseline and postexposure.
| Baseline
| Postexposure
| |||||
|---|---|---|---|---|---|---|
| Outcome | Mean ± SD | Range | Mean ± SD | Range | ||
| White blood cells (103/mm3) | 62 | 7.31 ± 1.6 | 3.6–10.4 | 7.3 ± 1.7 | 4.0–13.0 | 0.91 |
| Granulocytes (%) | 62 | 58.9 ± 7.2 | 43.5–76.0 | 58.2 ± 7.6 | 44.6–80.6 | 0.23 |
| Lymphocytes (%) | 62 | 30.7 ± 6.7 | 15.4–44.1 | 32.0 ± 7.3 | 15.7–47.0 | 0.069 |
| Monocytes (%) | 62 | 10.4 ± 3.5 | 4.5–19.4 | 9.8 ± 3.5 | 3.7–17.5 | 0.22 |
| LTL (T/S ratio) | 57 | 1.23 ± 0.28 | 0.68–1.86 | 1.43 ± 0.51 | 0.72–3.34 | < 0.001 |
| 58 | 1.68 ± 0.86 | 0.72–4.86 | 1.31 ± 0.75 | 0.52–5.55 | < 0.001 | |
| Position 1 | 59 | 93.9 ± 1.0 | 90.5–96.8 | 93.9 ± 1.1 | 89.9–96.8 | 0.84 |
| Position 2 | 59 | 93.8 ± 2.8 | 80.4–100.0 | 93.6 ± 3.1 | 79.2–97.1 | 0.67 |
| Position 3 | 59 | 90.0 ± 1.9 | 86.3–95.5 | 90.2 ± 1.5 | 85.9–93.2 | 0.36 |
The numbers of observations vary because of missing values due to failed laboratory analyses.
Figure 1Within-subject changes in LTL between the first day of a workweek (baseline) and after 3 days of work (postexposure). Individuals were categorized according to tertiles of PM10 exposure.
Association of PM10 and PM1 exposure with LTL and hTERT mRNA expression measured in foundry workers at baseline and postexposure.
| Dependent variable | Exposure | Unadjusted
| Adjusted | ||
|---|---|---|---|---|---|
| β | β | ||||
| LTL
| |||||
| Baseline ( | PM10 | 0.06 (−0.03 to 0.16) | 0.18 | 0.08 (−0.03 to 0.19) | 0.13 |
| PM1 | 0.02 (−0.11 to 0.15) | 0.71 | 0.07 (−0.09 to 0.22) | 0.38 | |
| Postexposure ( | PM10 | 0.26 (0.10 to 0.42) | 0.002 | 0.30 (0.11 to 0.49) | 0.002 |
| PM1 | 0.25 (0.02 to 0.48) | 0.037 | 0.29 (0.01 to 0.57) | 0.042 | |
| Difference | PM10 | 0.20 (0.07 to 0.33) | 0.003 | 0.23 (0.08 to 0.38) | 0.003 |
| PM1 | 0.22 (0.04 to 0.40) | 0.016 | 0.21 (0.00 to 0.43) | 0.051 | |
| Baseline ( | PM10 | −0.20 (−0.50 to 0.10) | 0.18 | −0.05 (−0.36 to 0.26) | 0.75 |
| PM1 | −0.41 (−0.80 to −0.01) | 0.042 | −0.15 (−0.57 to 0.27) | 0.47 | |
| Postexposure ( | PM10 | −0.07 (−0.33 to 0.19) | 0.60 | −0.02 (−0.30 to 0.26) | 0.89 |
| PM1 | −0.15 (−0.49 to 0.20) | 0.40 | −0.01 (−0.39 to 0.38) | 0.97 | |
| Difference | PM10 | 0.13 (−0.12 to 0.39) | 0.30 | 0.09 (−0.20 to 0.37) | 0.54 |
| PM1 | 0.26 (−0.08 to 0.60) | 0.13 | 0.20 (−0.16 to 0.57) | 0.27 | |
Regression coefficients, 95% confidence intervals (CIs), and p-values estimated from multivariable regression models adjusted for age, BMI, pack-years, and percent lymphocytes.
β for an increment equal to the difference between the 90th and 10th percentiles of exposure (285.96 μg/m3 for PM10 and 11.05 μg/m3 for PM1).
Values were missing for some subjects because of assay failure; statistical analysis was restricted to subjects with nonmissing values in both the baseline and the postexposure samples.
Postexposure – baseline.
Association of PM10 and PM1 exposure with the levels of methylation at three CpG positions in the promoter of hTERT at baseline and postexposure.
| Exposure | Unadjusted
| Adjusted | |||
|---|---|---|---|---|---|
| β | β | ||||
| CpG position 1
| |||||
| Baseline ( | PM10 | −0.02 (−0.39 to 0.36) | 0.93 | 0.08 (−0.34 to 0.50) | 0.71 |
| PM1 | −0.08 (−0.58 to 0.42) | 0.76 | −0.02 (−0.6 to 0.56) | 0.95 | |
| Postexposure ( | PM10 | −0.13 (−0.55 to 0.28) | 0.53 | −0.15 (−0.62 to 0.32) | 0.52 |
| PM1 | −0.13 (−0.68 to 0.43) | 0.65 | −0.13 (−0.76 to 0.50) | 0.69 | |
| Difference | PM10 | −0.11 (−0.65 to 0.42) | 0.67 | −0.24 (−0.84 to 0.36) | 0.43 |
| PM1 | −0.05 (−0.77 to 0.67) | 0.89 | −0.03 (−0.83 to 0.77) | 0.95 | |
| CpG position 2
| |||||
| Baseline ( | PM10 | 0.15 (−0.89 to 1.20) | 0.77 | 0.05 (−1.18 to 1.27) | 0.94 |
| PM1 | −0.15 (−1.55 to 1.26) | 0.83 | −0.32 (−2.00 to 1.36) | 0.71 | |
| Postexposure ( | PM10 | −0.26 (−1.41 to 0.89) | 0.65 | −0.43 (−1.75 to 0.89) | 0.52 |
| PM1 | −0.35 (−1.89 to 1.19) | 0.65 | −0.81 (−2.58 to 0.97) | 0.36 | |
| Difference | PM10 | −0.41 (−1.83 to 1.00) | 0.56 | −0.57 (−2.27 to 1.12) | 0.50 |
| PM1 | −0.20 (−2.11 to 1.70) | 0.83 | −0.33 (−2.59 to 1.93) | 0.77 | |
| CpG position 3
| |||||
| Baseline ( | PM10 | −0.20 (−0.91 to 0.50) | 0.56 | −0.21 (−1.00 to 0.59) | 0.61 |
| PM1 | −0.64 (−1.57 to 0.29) | 0.18 | −0.68 (−1.76 to 0.40) | 0.21 | |
| Postexposure ( | PM10 | −0.73 (−1.24 to −0.22) | 0.006 | −0.70 (−1.26 to −0.13) | 0.017 |
| PM1 | −1.00 (−1.69 to −0.32) | 0.005 | −1.00 (−1.76 to −0.25) | 0.010 | |
| Difference | PM10 | −0.53 (−1.19 to 0.13) | 0.12 | −0.55 (−1.30 to 0.20) | 0.15 |
| PM1 | −0.37 (−1.27 to 0.54) | 0.42 | −0.21 (−1.22 to 0.81) | 0.69 | |
Regression coefficients, 95% confidence intervals (CIs), and p-values estimated from multivariable regression models adjusted for age, BMI, pack-years, and percent lymphocytes.
β for an increment equal to the difference between the 90th and 10th percentiles of exposure (285.96 μg/m3 for PM10 and 11.05 μg/m3 for PM1).
Values were missing for some subjects because of assay failure; statistical analysis was restricted to subjects with nonmissing values in both the baseline and the postexposure samples.
Postexposure – baseline.